Member Info for MrSpeculator

SNG on BBC news channel 601 now if you are on Virgin lol

Looks like we will have a second push this afternoon.

Most will want to be in ahead of tomorrows news.

LOL

Thanks Deggsy

Live on the BBC news or do you have a link?

Proactive investors words not mine.....

https://www.proactiveinvestors.co.uk/companies/news/924544/ftse-100-pares-losses-as-uk-house-finances-recover-a-little-924544.html

Small-cap drug developer Synairgen (LON:SNG) looks to have discovered a life-saving treatment for acute cases of coronavirus (COVID-19).

It said the results from a recent trial “could signal a major breakthrough in the treatment of hospitalised patients”.

The shares soared 193% early on to 107p. Mark Brewer, an analyst at finnCap, has increased his price target for the stock to 360p.

He noted that quantifying the coronavirus opportunity was “nigh on impossible” as he admitted the valuation “could go substantially higher”.

What happens next will depend on the “upcoming discussions with regulators, which should clarify the route to market and the potential for buying SNG001 ahead of the winter 2020 flu season and the possibility of a second wave of COVID-19”

listen to 42 mins and 51 seconds on the webinar to be precise lol

Agreed the market cap here is so low.

And if I am struggling to buy into this at "punting" levels meaning I could not buy anything above a quantities of 1000 on shares com. might be local to that company who knows

But with the ready made media coverage coming tomorrow.....this will be blowing again.

They media questioning was very detailed but I think given the fact we are at the start of the journey it looks strong

Key point now is pharmas collaboration and interest

All the big hitters will be putting out articles tomorrow

The Guardian....
The Daily Mail....

They are all there

The Guardian are asking how to write the story....

Listen to the webinar from "38 minutes onwards" in particular the Guardian......

https://www.lsegissuerservices.com/spark/Synairgen/events/97cda0b9-0529-4be1-b1ca-471cc8dc1e94

This could hit £5-7 in next few days with press coverage alone. NCYT2 here we come

For me this is a punt and tbh I don't care if I am getting carried away. A share does not do 400% rises for no reason!

I should have went at 163p but was waiting for 160p lol

I could not buy any amount over 1000 shares with my trading company so had to buy in smaller tranches

Thanks for the link Ben

Hello all,

Sorry to ask novice questions lol but I haven't looked at this company for a while.

Is funding already there for the next stage of trials etc or is it a case of a Pharma coming in to help fund this or placing?

There will be plenty of interest in this share from the big pharmas and the US with 80% reduction in severe cases of Covid19!

If anyone can post the key points or fundamentals on SNG to save time for all us want to be investors or point us to reputable posters in SNG that be appreciated!

Gl all

Just been watching with interest from the sidelines. Bit cautious on being spiked.

But the market cap on this is so tiny. Starting to look worth a punt if it takes another breather....

It is good to see people's faith get rewarded.

I looked at this one but I didn't go with it.

Well done all!

Hello Taverham,

I cannot see any news for the rise over the last week.

I saw you posted on another board about an announcement happening this week.

Can you provide some more detail?

The spin off is already in the news

9 inchNail you are clueless. Look at the fundamentals.

- Look at the volumes that have traded this share over the last few weeks since it has become unsuspended
- Look at the Board holdings who own 20% of the company and are taking their remuneration is shares rather than salary
- Look at the buying pressures. The Buys vs Sells order book have been no less than 3-1 in favour of the buys for most of this week
- The share came off suspension and soared. The gains were held and then further pushed on which was backed up by buying by institutional investors at 17-20p.
- This company will not be entertaining offers below £1billion and that is the bottom end. So 30p-35p is bottom end of an offer
- The resource base of this company is in the multi billion and that is based on "conservative" estimates
- Flanks approvals and resource updates can further improve that.
- Multiple interested parties.
- Big Banks involved in the deal process "not" on a retainer....on a success fee only.
- The company has a good cash position.

How many more signs do you want

Of course there is risk involved but not many shares come along with so many ticks.

Let's hope this one comes off for everyone.

Go big or go home!

Gl all

Ok thanks Mac

Must be chinese whispers then

Gl all

I cannot remember the name of the poster but he posted about it on Friday evening.

Hello all,

A poster came onto this board saying that there was a lot of talk on Telegram app (I didn't even know what that was lol until I googled it) that the board had rejected a take.ver offer of 56p on Friday.

Has anyone been able to establish any credibility behind this? Who put the offer in? The source of the rumour?

What are peoples thoughts on this?

Obviously the company cannot come out and comment on every rumour.
But would they come out and make a statement if the rumour drove share price and confirm if it was true or not?

One thing we all noticed is that the market finished up strongly at 20p when it has failed to stabilise there all week.

I guess Monday morning would help indicate whether there is any credence to the rumours as a sharp move to 40p cannot happen on rumour alone right? The MMs would normally be privy to the sources of the rumours to see if they have credibility?

Hello all,

I have really been encouraged by all the replies to this thread.

A number of posters have mentioned the mass market potential of this test. I think we can all agree that if we do announce we are looking to produce 10s of millions of tests each month, it could really be a game changer.

I am not sure what the test price will be. Personally £25 felt a bit high to me. £1-12 was put out there, maybe at the mid to higher part of that range might feel more right but who knows. I take someones point about peace of mind for a test. I would pay £25 for Avacta's test. But I am thinking of the global reach to the poorer countries and equity. The fact that equity was on Alistairs mind from the start was a really good thing to hear.

So yes really exciting times. Hopefully we have news in the next few weeks.

The Southampton unit saliva test I mentioned earlier this week came up in the news. That actually helps raise awareness for saliva tests so is actually a good thing. I was a bit worried that we were not moving quick enough at the time. But I think getting the accuracy to the test is vital so investors including myself are willing to be patient as we believe in the end game. With our collaborations and distribution channels we can take the baton on.

Gl all

*previous investments involved in takeovers